Bora Biologics, a division of CDMO Bora Pharmaceuticals, will support DotBio, a biopharmaceutical company specializing in ...
J.P. Morgan analyst Pinjalim Bora has maintained their bullish stance on DT stock, giving a Buy rating on January 5.Stay Ahead of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback